Guardant Health Inc GH Stock Quotes and Insider News

Insider Chart Past 6 Months

Technical Chart

Filings by transaction date

Jan 11, 2021 (filed on Jan 13, 2021)

Insider Name:

Meresman Stanley J

Ownership Type:

Direct Ownership

Securities:

STOCK OPTION (RIGHT TO BUY)

Nature of Transaction:

M - Exercise or conversion exempt under rule 16b-3

# or value acquired/disposed of:

-4,934

Price:

--
Jan 11, 2021 (filed on Jan 13, 2021)

Insider Name:

Meresman Stanley J

Ownership Type:

Direct Ownership

Securities:

COMMON STOCK

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-4,934

Price:

$142.00
Jan 11, 2021 (filed on Jan 13, 2021)

Insider Name:

Meresman Stanley J

Ownership Type:

Direct Ownership

Securities:

COMMON STOCK

Nature of Transaction:

M - Exercise or conversion exempt under rule 16b-3

# or value acquired/disposed of:

4,934

Price:

$5.94
Jan 06, 2021 (filed on Jan 07, 2021)

Insider Name:

Eltoukhy Helmy

Ownership Type:

Direct Ownership

Securities:

COMMON STOCK

Nature of Transaction:

F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3

# or value acquired/disposed of:

-279,127

Price:

$129.54
Jan 06, 2021 (filed on Jan 07, 2021)

Insider Name:

Talasaz AmirAli

Ownership Type:

Direct Ownership

Securities:

COMMON STOCK

Nature of Transaction:

F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3

# or value acquired/disposed of:

-279,127

Price:

$129.54
Jan 04, 2021 (filed on Jan 06, 2021)

Insider Name:

Clark Ian T

Ownership Type:

Direct Ownership

Securities:

STOCK OPTION (RIGHT TO BUY)

Nature of Transaction:

M - Exercise or conversion exempt under rule 16b-3

# or value acquired/disposed of:

-2,690

Price:

--
Jan 04, 2021 (filed on Jan 06, 2021)

Insider Name:

Clark Ian T

Ownership Type:

Direct Ownership

Securities:

COMMON STOCK

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-2,690

Price:

$129.23
Jan 04, 2021 (filed on Jan 06, 2021)

Insider Name:

Clark Ian T

Ownership Type:

Direct Ownership

Securities:

COMMON STOCK

Nature of Transaction:

M - Exercise or conversion exempt under rule 16b-3

# or value acquired/disposed of:

2,690

Price:

$4.18
Jan 01, 2021 (filed on Jan 05, 2021)

Insider Name:

Eltoukhy Helmy

Ownership Type:

Direct Ownership

Securities:

Performance-Based Restricted Stock Units

Nature of Transaction:

M - Exercise or conversion exempt under rule 16b-3

# or value acquired/disposed of:

-565,192

Price:

--
Jan 01, 2021 (filed on Jan 05, 2021)

Insider Name:

Eltoukhy Helmy

Ownership Type:

Direct Ownership

Securities:

COMMON STOCK

Nature of Transaction:

M - Exercise or conversion exempt under rule 16b-3

# or value acquired/disposed of:

565,192

Price:

--

Filings by filing date

Jan 11, 2021 (filed on Jan 13, 2021)

Insider Name:

Meresman Stanley J

Ownership Type:

Direct Ownership

Securities:

STOCK OPTION (RIGHT TO BUY)

Nature of Transaction:

M - Exercise or conversion exempt under rule 16b-3

# or value acquired/disposed of:

-4,934

Price:

--
Jan 11, 2021 (filed on Jan 13, 2021)

Insider Name:

Meresman Stanley J

Ownership Type:

Direct Ownership

Securities:

COMMON STOCK

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-4,934

Price:

$142.00
Jan 11, 2021 (filed on Jan 13, 2021)

Insider Name:

Meresman Stanley J

Ownership Type:

Direct Ownership

Securities:

COMMON STOCK

Nature of Transaction:

M - Exercise or conversion exempt under rule 16b-3

# or value acquired/disposed of:

4,934

Price:

$5.94
Jan 06, 2021 (filed on Jan 07, 2021)

Insider Name:

Eltoukhy Helmy

Ownership Type:

Direct Ownership

Securities:

COMMON STOCK

Nature of Transaction:

F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3

# or value acquired/disposed of:

-279,127

Price:

$129.54
Jan 06, 2021 (filed on Jan 07, 2021)

Insider Name:

Talasaz AmirAli

Ownership Type:

Direct Ownership

Securities:

COMMON STOCK

Nature of Transaction:

F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3

# or value acquired/disposed of:

-279,127

Price:

$129.54
Jan 04, 2021 (filed on Jan 06, 2021)

Insider Name:

Clark Ian T

Ownership Type:

Direct Ownership

Securities:

STOCK OPTION (RIGHT TO BUY)

Nature of Transaction:

M - Exercise or conversion exempt under rule 16b-3

# or value acquired/disposed of:

-2,690

Price:

--
Jan 04, 2021 (filed on Jan 06, 2021)

Insider Name:

Clark Ian T

Ownership Type:

Direct Ownership

Securities:

COMMON STOCK

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-2,690

Price:

$129.23
Jan 04, 2021 (filed on Jan 06, 2021)

Insider Name:

Clark Ian T

Ownership Type:

Direct Ownership

Securities:

COMMON STOCK

Nature of Transaction:

M - Exercise or conversion exempt under rule 16b-3

# or value acquired/disposed of:

2,690

Price:

$4.18
Jan 01, 2021 (filed on Jan 05, 2021)

Insider Name:

Eltoukhy Helmy

Ownership Type:

Direct Ownership

Securities:

Performance-Based Restricted Stock Units

Nature of Transaction:

M - Exercise or conversion exempt under rule 16b-3

# or value acquired/disposed of:

-565,192

Price:

--
Jan 01, 2021 (filed on Jan 05, 2021)

Insider Name:

Eltoukhy Helmy

Ownership Type:

Direct Ownership

Securities:

COMMON STOCK

Nature of Transaction:

M - Exercise or conversion exempt under rule 16b-3

# or value acquired/disposed of:

565,192

Price:

--

News

Biz Brief

Sector: Healthcare	Industry: Biotechnology & Medical Research

See Regulatory Filings on SEC

Company Contact

Address:	505 Penobscot Dr REDWOOD CITY CA 94063-4737
Tel:	1-415-9375405
Website:	www.guardanthealth.com
IR:	See website

Key People

AmirAli Talasaz Chairman of the Board, President, Chief Operating Officer	Helmy A. Eltoukhy Chief Executive Officer, Director	Michael Bell Chief Financial Officer
Kumud Kalia Chief Information Officer	Michael J. Wiley Chief Legal Officer

Business Overview

Guardant Health, Inc. is a precision oncology company. The Company is focused on helping conquer cancer through use of its blood tests, data sets and analytics. It provides Guardant Health Oncology Platform. It provides liquid biopsy tests, such as Guardant360 and GuardantOMNI, for advanced stage cancer. Its liquid biopsy tests fuels its programs developing tests for recurrence and early detection, LUNAR-1 and LUNAR-2. Guardant360 is a molecular diagnostic test that measures 73 cancer-related genes from circulating tumor deoxyribonucleic acid (ctDNA). Its Guardant360 process includes blood collection, laboratory processing, analysis and reporting. Guardant360 is used for a range of applications, including translational science research and identifying target patient populations, drug development and commercialization post-drug approval.

Financial Overview

For the nine months ended 30 September 2020,Guardant Health Inc revenues increased 38% to $208.4M. Netloss increased from $50.4M to $160M. Revenues reflectUnited States segment increase of 42% to $191.6M,International segment increase of 1% to $16.8M. Higher netloss reflects Stock-based Compensation in increase from$3.7M to $72.6M (expense), Research and development expenseincrease of 83% to $102.2M (expense).

Employees:	622 as of Dec 31, 2019

Reporting Currency:	U.S. Dollars
Enterprise value:	$14,709M as of Sep 30, 2020
Annual revenue (TTM):	$271.31M as of Sep 30, 2020
EBITDA (TTM):	-$163.90M as of Sep 30, 2020
Net annual income (TTM):	-$185.25M as of Sep 30, 2020
Free cash flow (TTM):	-$128.84M as of Sep 30, 2020
Net Debt Last Fiscal Year:	N/A
Shares outstanding:	99,972,386 as of Oct 31, 2020
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization

INK Ultra Money Free

INK Ultra Money Videos

Guardant Health Inc (OQ:GH)